Matthew Durdy

Chief Executive

Matthew Durdy is Chief Executive of the Cell and Gene Therapy Catapult in the United Kingdom, an organisation he helped establish as part of its founding team in 2012 and has led as CEO since April 2020. Before taking the top role he served as Chief Business Officer, where he was responsible for strategy, communications, marketing and business development, and is credited with designing the commercial model behind the Catapult's manufacturing centre. He began his career in international investment banking and venture capital, and has since invested in and managed a number of biotechnology SMEs as well as the regional operations of multinational organisations. A biologist, investor and entrepreneur by background, he studied at the University of Chicago's Booth School of Business and is a global advocate for building healthcare economics and reimbursement expertise into clinical product design from the earliest stages of development.